Open access

Combining network pharmacology and experimental validation to explore the therapeutic mechanism of Banxia Xiexin decoction in type 2 diabetes mellitus

Li-Juan Du Yupeng Chen Xiu-Gang Zhang Ying-Ying Han Gao-Feng Qin Yi-Ting Tang Shi-Jie Han Yanhui Yang Quan-Lin Zhao Shou-Jun Song

Sep 2026 · 3 Biotech · Vol 16 · 0 citations · 54 references

Medicine

TL;DR

BXXD alleviates T2DM-associated metabolic dysregulation by activating the AMPK/SIRT1-mitophagy axis and suppressing inflammation, providing mechanistic evidence supporting further translational investigation of BXXD for T2DM.

DOI PubMed Semantic Scholar

Read PDF

Similar papers

Open access Aug 2026

Exploring the anti-inflammatory targets of Gui-qi-yi-shen granules in diabetic nephropathy: insights from network pharmacology, transcriptomics, and experimental verification

Results indicate that GQYS treats DN mainly through the anti-inflammatory effects, providing a potential theoretical basis for its clinical application and demonstrating the reliability of the integrative strategy.

Jia-Wei Cao, Meng-Dan Lu, Peng Bi et al. · RSC Advances · 0 citations

Open access Sep 2026

Investigating the Pharmacological Basis of Xiaochaihu-Tang in Diabetic Cognitive Impairment: A Network Pharmacology Approach

Background/Objectives: Diabetic Cognitive Impairment (DCI) involves cognitive impairment resulting from diabetes-triggered metabolic abnormalities and neuroinflammation; however, the therapeutic mechanisms of Xiaochaihu-tang (XCHT) remain unclear. Methods: This study systematically explored the potential pharmacologica...

B. Joo, Dong-Uk Kim, Bitna Kweon et al. · Brain Science · 0 citations

Open access Aug 2026

Integrating Network Pharmacology and Metabolomics to Decipher the Mechanisms Underlying the Therapeutic Effects of Wuzhi Dripping Pills Against MASLD

Background: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a progressive condition predisposing to cirrhosis and hepatocellular carcinoma, with prevalence rising globally. Yet effective therapies remain limited. Wuzhi Dripping Pills (WZDP), derived from Schisandra sphenanthera, possess hepatoprotec...

Hui-Jun Wang, Miao-Yuan Zhang, Kang-Kang Gao et al. · Metabolites · 0 citations

Sep 2026

Chemical characterization and pharmacological mechanisms of Qizhi Yishen Capsule in early diabetic kidney disease.

OBJECTIVE This research explored the bioactive components and therapeutic mechanisms of Qizhi Yishen Capsule (QZC) in managing early-stage diabetic kidney disease (DKD) by integrating network pharmacology with experimental evidence, aiming to support its clinical utility with scientific validation. METHODS Network ph...

Wen-Na Duan, Q. Jiang, Gui-Chun Shang et al. · Phytomedicine · 0 citations

Open access Aug 2026

Mechanism Study on Synergistic Regulation of Inflammatory-Metabolic Network in Type 2 Diabetes Mellitus by Multi-Components of Chinese Herbal Compound Formula

The progression of type 2 diabetes mellitus is closely interconnected with chronic low-grade inflammation and glycolipid metabolic disorders through complex network interactions. Intervention targeting a single molecular node fails to block the cascade amplification effects of such networks. Chinese herbal compound for...

Qing-Yu Jin, X.-Y. Qu, B.-J. Li et al. · Advanced Electromagnetics · 0 citations

Open access Sep 2026

Yiqi Huoxue Yangyin Decoction Ameliorates Diabetic Nephropathy by Targeting AMPK/mTOR-Mediated Autophagy: A Network Pharmacology-Guided in vivo and in vitro Study

Purpose This study aimed to investigate the protective effects and underlying mechanisms of Yiqi Huoxue Yangyin Decoction (YHY), a multi-herb formula composed of Astragalus membranaceus, Ligusticum chuanxiong, Pueraria lobata, Rehmannia glutinosa, and Trichosanthes kirilowii, against diabetic nephropathy (DN), focusing...

Zhi-Wei Xu, Jin-Xin He, Yang-Li Zhang et al. · Diabetes, Metabolic Syndrome... · 0 citations